(English) Chime Biologics congratulates Hope Medicine on HMI-115’s CDE Breakthrough Therapy Designation

申し訳ありません、このコンテンツはただ今 Englishと 中文 のみです。 For the sake of viewer convenience, the content is shown below in this site default language. You may click one of the links to switch the site language to another available language. Chime Biologics congratulates Hope Medicine on HMI-115’s CDE Breakthrough Therapy Designation Not available.

(English) Chime Biologics Successfully Hosts Fuel BioGrowth Chime Day 2024 Event

申し訳ありません、このコンテンツはただ今 Englishと 中文 のみです。 For the sake of viewer convenience, the content is shown below in this site default language. You may click one of the links to switch the site language to another available language. Chime Biologics Successfully Hosts Fuel BioGrowth Chime Day 2024 Event September 30, 2024, Wuhan – Chime Biologics, a leading global CDMO […]

(English) A Brief introduction on the Challenges and Strategies in Antibody Drug Production

申し訳ありません、このコンテンツはただ今 Englishと 中文 のみです。 For the sake of viewer convenience, the content is shown below in this site default language. You may click one of the links to switch the site language to another available language. A Brief introduction on the Challenges and Strategies in Antibody Drug Production No content available

(English) pilot-plant-of-chime-biologics

申し訳ありません、このコンテンツはただ今 Englishと 中文 のみです。 For the sake of viewer convenience, the content is shown below in this site default language. You may click one of the links to switch the site language to another available language.  pilot-plant-of-chime-biologics No content available

(English) Going Global – Chime Biologics Embraces Innovation and Quality with Partners

申し訳ありません、このコンテンツはただ今 Englishと 中文 のみです。 For the sake of viewer convenience, the content is shown below in this site default language. You may click one of the links to switch the site language to another available language. Going Global-Chime Biologics Embraces Innovation and Quality with Partners Foreign biopharmaceutical companies seek CDMO partners with long-term prospects, technology levels, and […]

(中文) 生物类似药中美欧法规速递

申し訳ありません、このコンテンツはただ今 中文 のみです。 For the sake of viewer convenience, the content is shown below in the alternative language. You may click the link to switch the active language.

(English) Whitepaper | Immunogenicity of Innovative and Biosimilar Monoclonal Antibodies

申し訳ありません、このコンテンツはただ今 Englishと 中文 のみです。 For the sake of viewer convenience, the content is shown below in this site default language. You may click one of the links to switch the site language to another available language.

(English) Domain Therapeutics and Chime Biologics announce manufacturing agreement to advance novel anti-CCR8 antibody for cancer immunotherapy

申し訳ありません、このコンテンツはただ今 Englishと 中文 のみです。 For the sake of viewer convenience, the content is shown below in this site default language. You may click one of the links to switch the site language to another available language. Domain Therapeutics and Chime Biologics announce manufacturing agreement to advance novel anti-CCR8 antibody for cancer immunotherapy The agreement combines Domain Therapeutics’ […]

(English) Chime Biologics and Hope Medicine Enter Manufacturing Agreement to Speed up the Launch of First-in-class Antibody Drug HMI-115 Targeting Endometriosis and Androgenic Alopecia

申し訳ありません、このコンテンツはただ今 Englishと 中文 のみです。 For the sake of viewer convenience, the content is shown below in this site default language. You may click one of the links to switch the site language to another available language. Chime Biologics and Hope Medicine Enter Manufacturing Agreement to Speed up the Launch of First-in-class Antibody Drug HMI-115 Targeting Endometriosis and […]

(English) Chime Biologics Enters into a Strategic Cooperation Agreement with Korea Kings Pharm to Accelerate the Biosimilar Launch

申し訳ありません、このコンテンツはただ今 Englishと 中文 のみです。 For the sake of viewer convenience, the content is shown below in this site default language. You may click one of the links to switch the site language to another available language. Chime Biologics Enters into a Strategic Cooperation Agreement with Korea Kings Pharm to Accelerate the Biosimilar Launch Chime Biologics has entered […]

categoryidArraymk-test